Aminopeptidase N reduces basolateral Na+-K+-ATPase in proximal tubule cells

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 4, 2007, Pages

  Kotlo, Kumar ^a   Shukla, Sagar ^a   Tawar, Urmila ^a   Skidgel, Randal A ^a   Danziger, Robert S ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Angiotensin IV; Kidney

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); MICROSOMAL AMINOPEPTIDASE; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME REGULATION; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 35348914765     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00074.2007     Document Type: Article

References (50)

1. Albiston AL, Fernando R, Ye S, Peck GR, Chai SY. Alzheimer's, angiotensin IV and an aminopeptidase. Biol Pharm Bull 27: 765-767, 2004.
2. Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, Connolly LM, Chai SY. Evidence that the angiotensin IV [AT(4)] receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 276: 48623-48626, 2001.
3. Albiston AL, Mustafa T, McDowall SG, Mendelsohn FA, Lee J, Chai SY. AT4 receptor is insulin-regulated membrane aminopeptidase: potential mechanisms of memory enhancement. Trends Endocrinol Metab 14: 72-77, 2003.
4. Aperia A. Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility. Curr Hypertens Rep 3: 165-171, 2001.
5. Bernier SG, Servant G, Boudreau M, Fournier A, Guillemette G. Characterization of a binding site for angiotensin IV on bovine aortic endothelial cells. Eur J Pharmacol 291: 191-200, 1995.
6. Braszko JJ. Involvement of D1 dopamine receptors in the cognitive effects of angiotensin IV and des-Phe6 angiotensin IV. Peptides 25: 1195-1203, 2004.
7. Chai SY, Fernando R, Peck G, Ye SY, Mendelsohn FA, Jenkins TA, Albiston AL. The angiotensin IV/AT4 receptor. Cell Mol Life Sci 61: 2728-2737, 2004.
8. Chen JK, Zimpelmann J, Harris RC, Burns KD. Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells. Am J Physiol Renal Physiol 280: F980-F988, 2001.
9. Choukroun GJ, Marshansky V, Gustafson CE, McKee M, Hajjar RJ, Rosenzweig A, Brown D, Bonventre JV. Cytosolic phospholipase A(2) regulates golgi structure and modulates intracellular trafficking of membrane proteins. J Clin Invest 106: 983-993, 2000.
10. Czekalski S, Chansel D, Vandermeersch S, Ronco P, Ardaillou R. Evidence for angiotensin IV receptors in human collecting duct cells. Kidney Int 50: 1125-1131, 1996.
11. Dantzler WH. Regulation of renal proximal and distal tubule transport: sodium, chloride and organic anions. Comp Biochem Physiol A Mol Integr Physiol 136: 453-478, 2003.
12. +-ATPase endocytosis. J Biol Chem 277: 44108-44114, 2002.
13. +-ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway. Am J Physiol Cell Physiol 279: C1685-C1693, 2000.
14. +-ATPase: molar and specific activity, protein determination. Methods Enzymol 156: 105-115, 1988.
15. Esteban V, Ruperez M, Sanchez-Lopez E, Rodriguez-Vita J, Lorenzo O, Demaegdt H, Vanderheyden P, Egido J, Ruiz-Ortega M. Angiotensin IV activates the nuclear transcription factor-κB and related proinflammatory genes in vascular smooth muscle cells. Circ Res 96: 965-973, 2005.
16. Farjah M, Roxas B, Danziger RS. Dietary NaCl regulates in renal APN transcript/protein abundance and activity: relevance to hypertension in the Dahl rat. Hypertension 43: 282-285, 2004.
17. Faure S, Javellaud J, Achard JM, Oudart N. Vasoconstrictive effect of angiotensin IV in isolated rat basilar artery independent of AT1 and AT2 receptors. J Vasc Res 43: 19-26, 2006.
18. Gottardi CJ, Dunbar LA, Caplan MJ. Biotinylation and assessment of membrane polarity: caveats and methodological concerns. Am J Physiol Renal Fluid Electrolyte Physiol 268: F285-F295, 1995.
19. Grove KL, Deschepper CF. High salt intake differentially regulates kidney angiotensin IV AT4 receptors in Wistar-Kyoto and spontaneously hypertensive rats. Life Sci 64: 1811-1818, 1999.
20. +-ATPase activity via a NO/cGMP-dependent pathway. Am J Physiol Renal Physiol 290: F1430-F1436, 2006.
21. Hamilton TA, Handa RK, Harding JW, Wright JW. A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat. Peptides 22: 935-944, 2001.
22. Handa RK. Characterization and signaling of the AT(4) receptor in human proximal tubule epithelial (HK-2) cells. J Am Soc Nephrol 12: 440-449, 2001.
23. Handa RK, Krebs LT, Harding JW, Handa SE. Angiotensin IV AT4-receptor system in the rat kidney. Am J Physiol Renal Physiol 274: F290-F299, 1998.
24. Herbst JJ, Ross SA, Scott HM, Bobin SA, Morris NJ, Lienhard GE, Keller SR. Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes. Am J Physiol Endocrinol Metab 272: E600-E606, 1997.
25. Kenny AJ, Maroux S. Topology of microvillar membrance hydrolases of kidney and intestine. Physiol Rev 62: 91-128, 1982.
26. Kotlo K, Hughes DE, Herrera VL, Ruiz-Opazo N, Costa RH, Robey RB, Danziger RS. Functional polymorphism of the Anpepgene increases promoter activity in the Dahl salt-resistant rat promoter. Hypertension 49: 1-6, 2007.
27. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144: 2179-2183, 2003.
28. Leong PK, Devillez A, Sandberg MB, Yang LE, Yip DK, Klein JB, McDonough AA. Effects of ACE inhibition on proximal tubule sodium transport. Am J Physiol Renal Physiol 290: F854-F863, 2006.
29. Li YD, Block ER, Patel JM. Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation. Am J Physiol Lung Cell Mol Physiol 283: L707-L716, 2002.
30. Lochard N, Thibault G, Silversides DW, Touyz RM, Reudelhuber TL. Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist. Circ Res 94: 1451-1457, 2004.
31. Matsas R, Stephenson SL, Hryszko J, Kenny AJ, Turner AJ. The metabolism of neuropeptides. Phase separation of synaptic membrane preparations with Triton X-114 reveals the presence of aminopeptidase. N Biochem J 231: 445-449, 1985.
32. + transport in the rat. BMC Pharmacol 4: 1, 2004.
33. +-ATPase activity in Dahl salt-resistant but not in Dahl salt-sensitive rats: evidence of defective dopamine regulation. Acta Physiol Scand 144: 263-267, 1992.
34. +-ATPase in Dahl salt-sensitive rats. Am J Physiol Renal Fluid Electrolyte Physiol 264: F448-F452, 1993.
35. Noren O, Sjostrom H, Olsen J. Aminopeptidase N. In: Cell-Surface Peptidases in Health and Disease, edited by Kenny AJ and Boustead CM. Oxford: BIOS Scientific, 1997, p. 175-191.
36. +-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin. Proc Natl Acad Sci USA 97: 3242-3247, 2000.
37. Olsen J, Kokholm K, Noren O, Sjostrom H. Structure and expression of aminopeptidase N. Adv Exp Med Biol 421: 47-57, 1997.
38. 1 cells. Am J Physiol Renal Physiol 290: F997-F1008, 2006.
39. Paul M, Poyan MA, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803, 2006.
40. Pedemonte CH, Efendiev R, Bertorello AM. Inhibition of Na,K-ATPase by dopamine in proximal tubule epithelial cells. Semin Nephrol 25: 322-327, 2005.
41. +-ATPase in proximal tubule cells. Kidney Int 67: 1868-1877, 2005.
42. Poumarat JS, Houillier P, Rismondo C, Roques B, Lazar G, Paillard M, Blanchard A. The luminal membrane of rat thick limb expresses AT1 receptor and aminopeptidase activities. Kidney Int 62: 434-445, 2002.
43. Prieto I, Hermoso F, Gasparo M, Vargas F, Alba F, Segarra AB, Banegas I, Ramirez M. Angiotensinase activities in the kidney of renovascular hypertensive rats. Peptides 24: 755-760, 2003.
44. Riemann D, Kehlen A, Langner J. CD13-not just a marker in leukemia typing. Immunol Today 20: 83-88, 1999.
45. Sakai K, Sigmund CD. Molecular evidence of tissue renin-angiotensin systems: a focus on the brain. Curr Hypertens Rep 7: 135-140, 2005.
46. Scavone C, Scanlon C, McKee M, Nathanson JA. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. J Pharmacol Exp Ther 272: 1036 -1043, 1995.
47. Sjostrom H, Noren O, Olsen J. Structure and function of aminopeptidase N. Adv Exp Med Biol 477: 25-34, 2000.
48. Ward PE, Benter IF, Dick L, Wilk S. Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M. Biochem Pharmacol 40: 1725-1732, 1990.
49. Wright JW, Krebs LT, Stobb JW, Harding JW. The angiotensin IV system: functional implications. Front Neuroendocrinol 16: 23-52, 1995.
50. Zhang Y, Norian JM, Magyar CE, Holstein-Rathlou NH, Mircheff AK, McDonough AA. In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition. Am J Physiol Renal Physiol 276: F711-F719, 1999.